DEVELOPMENT OF IDARUBICIN AND DOXORUBICIN SOLID LIPID NANOPARTICLES TO OVERCOME PGP–MEDIATED MULTIPLE DRUG RESISTANCE IN LEUKEMIA

MA, P., DONG, X., & SWADLEY, C.L.. (2009). DEVELOPMENT OF IDARUBICIN AND DOXORUBICIN SOLID LIPID NANOPARTICLES TO OVERCOME PGP–MEDIATED MULTIPLE DRUG RESISTANCE IN LEUKEMIA. JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 5(2), 151-161. SID. https://sid.ir/paper/640013/en

MA P., DONG X., SWADLEY C.L.. DEVELOPMENT OF IDARUBICIN AND DOXORUBICIN SOLID LIPID NANOPARTICLES TO OVERCOME PGP–MEDIATED MULTIPLE DRUG RESISTANCE IN LEUKEMIA. JOURNAL OF BIOMEDICAL NANOTECHNOLOGY[Internet]. 2009;5(2):151-161. Available from: https://sid.ir/paper/640013/en

P. MA, X. DONG, and C.L. SWADLEY, “DEVELOPMENT OF IDARUBICIN AND DOXORUBICIN SOLID LIPID NANOPARTICLES TO OVERCOME PGP–MEDIATED MULTIPLE DRUG RESISTANCE IN LEUKEMIA,” JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, vol. 5, no. 2, pp. 151–161, 2009, [Online]. Available: https://sid.ir/paper/640013/en